نتائج البحث

1

Expression pattern of ALDH1, E-cadherin, Vimentin and Twist in early and late onset sporadic colorectal cancer

المؤلفون: Nachimuthu Senthil Kumar, Litika Vermani, Rajeev Kumar, Anuradha Talukdar, Monoj K. Deka, Rengaswamy R Kannan

المصدر: Biomarkers in Medicine. 14:1371-1382

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37a64511586c7d1f5e0f318bba1b5df9Test
https://doi.org/10.2217/bmm-2020-0206Test

2

Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design

المؤلفون: Tuochuan Dong, Tony Sk Mok, Jay M. Lee, Masahiro Tsuboi, Cecile Blin, Ana Gómez-Rueda, Edward S. Kim, Vanessa Q. Passos, Vanessa Rodrik-Outmezguine, Pilar Garrido, Luis Gorospe, Jean-Louis Pujol, Amparo Benito, Nicolas Moreno

المصدر: Future Oncology. 17:1459-1472

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Adolescent, medicine.medical_treatment, Interleukin-1beta, Programmed Cell Death 1 Receptor, Disease, Pembrolizumab, Antibodies, Monoclonal, Humanized, Young Adult, 03 medical and health sciences, Clinical Trials, Phase II as Topic, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Humans, Medicine, Pneumonectomy, Lung cancer, Lung, Neoplasm Staging, Randomized Controlled Trials as Topic, business.industry, General Medicine, Immunotherapy, medicine.disease, Neoadjuvant Therapy, Immune checkpoint, Clinical trial, Canakinumab, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::533cf87894d6775fc54f655766423e45Test
https://doi.org/10.2217/fon-2020-1098Test

3

First-line treatment of advanced/metastatic melanoma with anti-PD-1 antibodies: multicenter experience in Poland

المصدر: Immunotherapy. 13:297-307

مصطلحات موضوعية: Adult, Male, Oncology, medicine.medical_specialty, Multivariate analysis, Drug-Related Side Effects and Adverse Reactions, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Immunology, Pembrolizumab, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Humans, Immunology and Allergy, Medicine, 030212 general & internal medicine, Stage (cooking), Adverse effect, Immune Checkpoint Inhibitors, Melanoma, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Immunotherapy, Middle Aged, Prognosis, medicine.disease, Progression-Free Survival, Survival Rate, Clinical trial, Nivolumab, Treatment Outcome, 030220 oncology & carcinogenesis, Female, Poland, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75481f1f9c5cc0cca549a49f8bad084dTest
https://doi.org/10.2217/imt-2020-0217Test

4

Phase III study of nivolumab alone or combined with ipilimumab as immunotherapy versus standard of care in resectable head and neck squamous cell carcinoma

المؤلفون: Adrian Muenscher, Philippe Schafhausen, Henrike Barbara Zech, Nikolaus Moeckelmann, Mascha Binder, Arne Boettcher, Christian Stephan Betz, Chia-Jung Busch, Eik Vettorazzi, Carsten Bokemeyer

المصدر: Future Oncology. 16:3035-3043

مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Mitomycin, Programmed Cell Death 1 Receptor, Ipilimumab, Disease-Free Survival, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Adjuvant therapy, Clinical endpoint, Humans, Medicine, CTLA-4 Antigen, Prospective Studies, 030223 otorhinolaryngology, Immune Checkpoint Inhibitors, Neoplasm Staging, Squamous Cell Carcinoma of Head and Neck, business.industry, Head and neck cancer, Chemoradiotherapy, Adjuvant, General Medicine, Middle Aged, medicine.disease, Head and neck squamous-cell carcinoma, Neoadjuvant Therapy, Clinical trial, stomatognathic diseases, Nivolumab, Chemotherapy, Adjuvant, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Female, Fluorouracil, Cisplatin, Neoplasm Recurrence, Local, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41f2b4123f6aefe3592460ca34f1940eTest
https://doi.org/10.2217/fon-2020-0595Test

5

MiR-29a inhibits invasion and metastasis of cervical cancer via modulating methylation of tumor suppressor SOCS1

المؤلفون: Jun-Li Qin, Yi Gong, Wei Zou, Guang-Yu Lian, Junhui Wan, Qing-Ming Wang

المصدر: Future Oncology. 15:1729-1744

مصطلحات موضوعية: Adult, DNA (Cytosine-5-)-Methyltransferase 1, 0301 basic medicine, Cancer Research, Epithelial-Mesenchymal Transition, Bisulfite sequencing, Uterine Cervical Neoplasms, Apoptosis, Decitabine, Metastasis, 03 medical and health sciences, Suppressor of Cytokine Signaling 1 Protein, 0302 clinical medicine, Downregulation and upregulation, Cell Movement, Genes, Reporter, Cell Line, Tumor, medicine, Humans, Neoplasm Invasiveness, Neoplasm Metastasis, Aged, Cell Proliferation, Neoplasm Staging, Suppressor of cytokine signaling 1, business.industry, NF-kappa B, General Medicine, Methylation, DNA Methylation, Middle Aged, medicine.disease, Gene Expression Regulation, Neoplastic, Blot, MicroRNAs, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Cancer research, Female, RNA Interference, Signal transduction, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c3d916c914883f25744a63732cd7fdbTest
https://doi.org/10.2217/fon-2018-0497Test

6

Real-world use of talimogene laherparepvec in Germany: a retrospective observational study using a prescription database

المؤلفون: Sebastian Haferkamp, Florian Scholz, Hartmut Richter, Victoria Banks, Peter Mohr, Katarina Öhrling, Karly S. Louie

المصدر: Future Oncology. 16:317-328

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Volume Administered, Databases, Factual, Patient characteristics, Herpesvirus 1, Human, Kaplan-Meier Estimate, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Prescription database, Germany, Internal medicine, medicine, Humans, Summary of Product Characteristics, Medical prescription, Melanoma, Aged, Retrospective Studies, Aged, 80 and over, Oncolytic Virotherapy, Biological Products, business.industry, Retrospective cohort study, General Medicine, Guideline, Middle Aged, Prognosis, Combined Modality Therapy, Oncolytic Viruses, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Female, Talimogene laherparepvec, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c95bbaa7aa6794049cfd27431febefc9Test
https://doi.org/10.2217/fon-2019-0838Test

7

KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma

المؤلفون: Piotr Rutkowski, Sama Ahsan, Jean-Jacques Grob, Matteo S. Carlino, James R. Anderson, Merrick I. Ross, John M. Kirkwood, Jeffrey E. Gershenwald, Caroline Robert, Jason J. Luke, Nageatte Ibrahim, Charles H. Yoon, Peter Mohr, Georgina V. Long, Alexander M.M. Eggermont, Axel Hauschild, Paolo A. Ascierto, Andrew Poklepovic, Richard A. Scolyer

المصدر: Future Oncology. 16:4429-4438

مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Adolescent, medicine.medical_treatment, Dermatologic Surgical Procedures, Programmed Cell Death 1 Receptor, Pembrolizumab, Antibodies, Monoclonal, Humanized, Placebo, Disease-Free Survival, Placebos, Young Adult, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Internal medicine, medicine, Adjuvant therapy, Humans, Multicenter Studies as Topic, 030212 general & internal medicine, Young adult, Child, Melanoma, Neoplasm Staging, Randomized Controlled Trials as Topic, Cross-Over Studies, business.industry, General Medicine, medicine.disease, Crossover study, Clinical trial, Clinical Trials, Phase III as Topic, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, business, Adjuvant

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6a00dd1a28f82ed3c8216b416ba2d53Test
https://doi.org/10.2217/fon-2019-0666Test

8

Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis

المؤلفون: Maxwell Chirehwa, Katya Govender, Kogieleum Naidoo, Sinaye Ncgapu, Paolo Denti, Ravesh Singh, John W. Adamson, Nonhlanhla Yende-Zuma, Helen McIlleron, Nesri Padayatchi, Anushka Naidoo, Veron Ramsuran

المصدر: Pharmacogenomics. 20:225-240

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfef653446ab981495bcfe7cd449f518Test
https://doi.org/10.2217/pgs-2018-0166Test

9

BRAFi/MEKi in patients with metastatic melanoma: predictive factors of complete response

المؤلفون: Maria Teresa Fierro, Virginia Caliendo, Simone Ribero, Simona Osella-Abate, Martina Sanlorenzo, Ottavia Malavenda, Pietro Quaglino, Paolo Fava, Chiara Astrua, Elena Marra

المصدر: Future Oncology. 15:133-139

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Skin Neoplasms, MAP Kinase Kinase 1, combination therapy, 0302 clinical medicine, Piperidines, Antineoplastic Combined Chemotherapy Protocols, Oximes, MEK inhibitors, Complete response, Aged, 80 and over, Trametinib, Melanoma, Imidazoles, BRAF inhibitors, General Medicine, Middle Aged, Treatment Outcome, 030220 oncology & carcinogenesis, Female, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Metastatic melanoma, Combination therapy, Pyridones, melanoma, Pyrimidinones, 03 medical and health sciences, Internal medicine, medicine, Humans, In patient, Protein Kinase Inhibitors, Aged, Retrospective Studies, business.industry, Dabrafenib, medicine.disease, 030104 developmental biology, Survival benefit, Vemurafenib, Mutation, Azetidines, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5fa36af49f03985cb916fae76f51f9fTest
https://doi.org/10.2217/fon-2018-0386Test

10

Methylation profiles of IL33 and CCL26 in bronchial epithelial cells are associated with asthma

المؤلفون: Valérie Gagné-Ouellet, Sophie Plante, Marie-Chantal Larose, Anne-Marie Boucher-Lafleur, Nicolas Flamand, Jamila Chakir, Michel Laviolette, Anne-Marie Madore, Catherine Laprise, Miriam Larouche

المصدر: Epigenomics. 10:1555-1568

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9d3bd2548d40da15179fd92a6462141Test
https://doi.org/10.2217/epi-2018-0044Test

تنقيح النتائج